Gene therapy for Spinal Muscular Atrophy by a correction of SMN2 MRNA splicing
Principal investigator(s) :
Dr. Rachel Nlend NlendInstitution :
Universität Bern, SwitzerlandGrant :
65,000 €Grant Type:
Operating GrantCall number :
2Start year :
2010Duration :
2 yearsStatus :
null